Physicians International Coronary Computed Tomography Angiography (CCTA) Utilization Registry (BIGPICTURE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00932958|
Recruitment Status : Completed
First Posted : July 7, 2009
Last Update Posted : December 11, 2012
This protocol describes an observational study whose goal is to collect de-identified Coronary CT Angiography (CCTA) acquisition factors and interpretations (findings) from several hundred U.S. and international imaging facilities. The study uses an electronic data capture tool to collect de-identified CCTA utilization parameters and clinical findings in order to create a multi-center registry. This registry will be used for scientific analysis and publication of pertinent medical trends such as CT utilization, radiation dose, and common cardiovascular findings. The registry will be used to determine areas of interest for future randomized controlled trials.
All data will be collected with patient identifiers removed and in complete accordance with HIPAA regulations. All data will be analyzed in aggregate, thus further minimizing the risk of patient confidentiality violations.
|Condition or disease|
|Coronary Artery Disease|
|Study Type :||Observational|
|Actual Enrollment :||6000 participants|
|Official Title:||Physicians International CCTA Utilization Registry|
|Study Start Date :||May 2009|
|Primary Completion Date :||December 2011|
|Study Completion Date :||December 2011|
All comers >18 yrs old
This study is observational, studying patients who are already scheduled to undergo CCTA. Minors and those unable to consent to the study are excluded.
- CCTA utilization parameters and clinical findings [ Time Frame: Two years ]
- 90 day MACE, Intended Care Management and Cost Effectiveness for cardiologists interpreting their CCTA studies [ Time Frame: Two years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00932958
|United States, California|
|San Francisco, California, United States, 94111|
|Study Director:||Dan Gebow, PhD||MDDX LLC|